Senores Pharmaceuticals Limited — Updates, 06-11-2025: Press Release
06-11-2025 | 02:11 pm
06-11-2025 | 02:11 pm
Senores Pharma reported robust Q2FY26/H1FY26 results. Q2 revenue surged 61% to Rs. 162 Cr, PAT soared 131% to Rs. 30 Cr. Strong growth in regulated markets and branded generics, along with improved operating cash flow, drove performance.
No comments yet. Be the first to comment!
